ArticleHeliyon2022

Effectiveness and toxicity of metronomic oral cyclophosphamide for recurrent or platinum-refractory ovarian cancer: A meta-analysis.

Lili Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.